Prostatic Neoplasms: all 6,484 studies

Page 20 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.

• Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate CancerTerminatedNCT02057666Phase 3Results posted
• A Safety and Feasibility Study of Mitotane in Prostate CancerCompletedNCT02057237Phase 1Results posted
• Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following TreatmentCompletedNCT02047253Phase 2Results posted
• Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild SymptomsCompletedNCT02043678Phase 3Results posted
• A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)CompletedNCT02034552Phase 2Results posted
• Treatment Preference and Patient Centered Prostate Cancer CareCompletedNCT02032550Not applicableResults posted
• Enzalutamide + External Beam Rt For ProstateCompletedNCT02028988Phase 2Results posted
• Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate CancerCompletedNCT02025010Phase 2Results posted
• Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the BoneCompletedNCT02023697Phase 2Results posted
• An Open-label Extension Study of PSMA ADC 2301 in mCRPCCompletedNCT02020135Phase 2Results posted
• Fusion Targeted Biopsy of the ProstateCompletedNCT02013414Not applicableResults posted
• Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer DetectionCompletedNCT02013180Results posted
• Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate CancerCompletedNCT02012296Phase 1/2Results posted
• A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid TumorsCompletedNCT02009449Phase 1Results posted
• A Pilot Study of the Feasibility of Chronic Cavernous Nerve Stimulation to Promote Regeneration and Erectile FunctionTerminatedNCT02006927Not applicableResults posted
• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate CancerCompletedNCT02003924Phase 3Results posted
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsCompletedNCT02001623Phase 1/2Results posted
• Improving Erectile Function and Quality of Life After Prostate Cancer TreatmentTerminatedNCT01996852Not applicableResults posted
• Safety Study of Continued Enzalutamide Treatment In Prostate Cancer PatientsCompletedNCT01995513Phase 4Results posted
• Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPCTerminatedNCT01995058Phase 2Results posted
• Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)TerminatedNCT01994590Phase 2Results posted
• A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor RanolazineCompletedNCT01992016Not applicableResults posted
• Functional MRI Use in Prostate Radiation Treatment PlanningCompletedNCT01985932Not applicableResults posted
• CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate CancerCompletedNCT01985828Not applicableResults posted
• Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate CancerCompletedNCT01982786Not applicableResults posted
• A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate CancerCompletedNCT01981122Phase 2Results posted
• Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate CancerTerminatedNCT01981109Results posted
• Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.CompletedNCT01972217Phase 2Results posted
• Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate CancerCompletedNCT01967862Not applicableResults posted
• Perioperative Post-Prostatectomy Incontinence Home Telehealth ProgramCompletedNCT01960998Not applicableResults posted
• Early Changes In Multiparametric MRI In Prostate CancerCompletedNCT01959542Not applicableResults posted
• Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerActive, not recruitingNCT01949337Phase 3Results posted
• A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT01946204Phase 3Results posted
• Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and EnzalutamideCompletedNCT01946165Phase 2Results posted
• Study of Enzalutamide in Patients With Castration-resistant Prostate CancerCompletedNCT01942837Phase 2Results posted
• Abiraterone Race in Metastatic Castrate-resistant Prostate CancerCompletedNCT01940276Phase 2Results posted
• Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone MetastasesCompletedNCT01934790Phase 1/2Results posted
• Green Tea Extract in Treating Patients With Low-Risk Prostate CancerTerminatedNCT01928485Phase 2Results posted
• Enzalutamide in Patients With High-risk Prostate CancerCompletedNCT01927627Phase 2Results posted
• Optimizing Veteran-Centered Prostate Cancer Survivorship CareCompletedNCT01900561Not applicableResults posted
• Tivozanib + Enzalutamide in Adv Prostate CancerTerminatedNCT01885949Phase 2Results posted
• Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer PatientsCompletedNCT01882985Phase 2Results posted
• CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT01881867Phase 2Results posted
• Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate CancerCompletedNCT01875250Phase 2Results posted
• Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to ChemotherapyCompletedNCT01867710Phase 2Results posted
• Gadoxetate Enhanced Imaging Study to Detect Prostate CancerCompletedNCT01867424Phase 2Results posted
• Enzalutamide With or Without Vaccine Therapy for Advanced Prostate CancerCompletedNCT01867333Phase 2Results posted
• Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate CancerTerminatedNCT01866423Phase 2Results posted
• A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate CancerCompletedNCT01858688Not applicableResults posted
• Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)CompletedNCT01856855Not applicableResults posted
• Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate CancerCompletedNCT01848067Phase 1/2Results posted
• Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate CancerTerminatedNCT01845792Phase 2Results posted
• A Couple Support Intervention for Prostate CancerCompletedNCT01842438Not applicableResults posted
• A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral MetastasesCompletedNCT01834651Phase 2Results posted
• Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate CancerTerminatedNCT01828476Phase 2Results posted
• Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate CancerCompletedNCT01824342Phase 3Results posted
• Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing SurgeryCompletedNCT01823562Phase 1Results posted
• Sipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Metastatic Castrate-resistant Prostate Cancer (mCRPC)CompletedNCT01818986Phase 2Results posted
• NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone MetastasisTerminatedNCT01816048Phase 2Results posted
• Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate CancerCompletedNCT01815515Phase 1/2Results posted
• Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate CancerCompletedNCT01812668Not applicableResults posted
• S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate CancerCompletedNCT01809691Phase 3Results posted
• FACBC for Recurrent Prostate CancerCompletedNCT01808222Phase 2Results posted
• Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate CancerCompletedNCT01807065Phase 2Results posted
• Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical ProstatectomyCompletedNCT01804712Early Phase 1Results posted
• Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate CancerCompletedNCT01804465Phase 2Results posted
• Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone TherapyCompletedNCT01800058Results posted
• A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate CancerCompletedNCT01799278Phase 2Results posted
• Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate SurgeryTerminatedNCT01794936Not applicableResults posted
• Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesCompletedNCT01794793Phase 4Results posted
• MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate CancerCompletedNCT01792024Not applicableResults posted
• The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate CancerCompletedNCT01790126Phase 2Results posted
• Itraconazole in Treating Patients With Biochemically Relapsed Prostate CancerCompletedNCT01787331Phase 2Results posted
• Study of 89Zr-DFO-MSTP2109A in Patients With Prostate CancerCompletedNCT01774071Phase 1/2Results posted
• Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized TrialCompletedNCT01759771Phase 2Results posted
• A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.CompletedNCT01753297Phase 4Results posted
• 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical ProstatectomyCompletedNCT01751451Phase 2Results posted
• Bipolar Androgen-based Therapy for Prostate Cancer (BAT)CompletedNCT01750398Phase 2Results posted
• A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate BiopsyTerminatedNCT01748890Not applicableResults posted
• Abiraterone Acetate Trial in African American Prostate Cancer PatientsTerminatedNCT01735396Phase 2Results posted
• A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based ChemotherapyTerminatedNCT01732549Phase 2Results posted
• Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT01731912Not applicableResults posted
• Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-TTerminatedNCT01727154Results posted
• Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)CompletedNCT01718353Phase 2Results posted
• A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate CancerTerminatedNCT01717898Phase 1/2Results posted
• [F-18] Fluorothymidine PET/CT Imaging for Pelvic CancersCompletedNCT01717391Phase 2Results posted
• Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate CancerCompletedNCT01717053Phase 2Results posted
• A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)CompletedNCT01715285Phase 3Results posted
• Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate CancerCompletedNCT01715129Phase 3Results posted
• Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer PatientsCompletedNCT01715064Phase 2/3Results posted
• Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate CancerCompletedNCT01706458Phase 2Results posted
• Study to Assess the Activity of Nexrutine® in Prostate Cancer PatientsTerminatedNCT01705652Phase 2Results posted
• Cabozantinib in Men With Castration-Resistant Prostate CancerTerminatedNCT01703065Phase 2Results posted
• A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate CancerCompletedNCT01696877Phase 1/2Results posted
• Neoadjuvant BKM120 in High-risk Prostate CancerTerminatedNCT01695473Phase 2Results posted
• A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based ChemotherapyCompletedNCT01695135Phase 3Results posted
• A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)CompletedNCT01695044Phase 2Results posted
• Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate CancerCompletedNCT01686958Not applicableResults posted
• A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate CancerCompletedNCT01685983Phase 2Results posted
• Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate CancerCompletedNCT01683994Phase 1/2Results posted

← Prostatic Neoplasms overview